Justin Smerker, PharmD, MSPBA

The ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.

Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.

The transition to value-based reimbursement is likely to shape the future of health care.

There is little room for error in the highly competitive specialty pharmacy landscape.